Sign up to access historical data
Similar companies
Company | Est. Transaction Value | |
---|---|---|
Abbott LaboratoriesABT |
-$110,000 | |
TeleflexTFX |
$8,000 | |
HCA HealthcareHCA |
-$57,000 | |
Waters CorporationWAT |
-$8,000 | |
Cardinal HealthCAH |
$83,000 |
Trades by US Politicians
Politician | Filing Date | Type | Size |
---|---|---|---|
Rohit Khanna Democrat | Mar 24, 2023 | Sell | $1K - $15K |
Rohit Khanna Democrat | Mar 14, 2023 | Sell | $1K - $15K |
Rohit Khanna Democrat | Jan 11, 2023 | Buy | $1K - $15K |
Who is the latest politician to buy or sell Universal Health Services shares?
Rohit Khanna sold Universal Health Services shares most recently on March 24, 2023.
Which politician has bought the most UHS stock in the last two years?
Rohit Khanna has bought the most UHS stock in the last 2 years, with an estimated value of $8,000.
Which politician has sold the most UHS stock over the last two years?
Rohit Khanna has sold the most UHS stock in the last 2 years, with an estimated value of $16,000.
What is the total value of politicians trading UHS stock in the last 2 years?
The net value of trades by US politicians for Universal Health Services in the last 2 years is negative, amounting to -$8,000. This suggests that US politicians do not believe in the success of the company for various reasons.
How do insider transactions over the last 2 years reflect on Universal Health Services' market confidence?
Over the last 2 years, insider transactions for Universal Health Services have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering politicians might have insights or reasons not immediately apparent to the public.
Why should individual investors pay attention to the stock transactions of US politicians?
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.